EGFR and non-small cell lung carcinoma: From a clinical perspective, these methods offer alternative diagnostic techniques when a tissue biopsy is insufficient or not viable to determine EGFR T790M resistance mutation in NSCLC patients who harbour EGFR mutations, and also when the disease progresses.